Join
Live feed
·
INSIDERFilingvia Quantisnow
Akebia Therapeutics Inc. logo

Grund Nicholas was granted 303,300 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AKBA· Akebia Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKBA (Akebia Therapeutics Inc.) and more on Quantisnow.